Natural Alternatives International, Inc

Natural Alternatives International, Inc. manufactures private-label nutritional supplements for brands that sell vitamins, minerals, herbs, and other health products to consumers in the U.S. and abroad. It also monetizes its beta-alanine intellectual property through CarnoSyn®, SR CarnoSyn®, and TriBsyn™ raw material sales, licensing, and royalty arrangements.

−3,2 %

7,2 %

−10,5 %

+14,1 %

2.06

1.19

— Natural Alternatives International, Inc
%
Private-label contract manufacturing88% Manufacturing of finished nutritional supplement products for third-party brands under customer specifications.
Patent and trademark licensing12% Licensing and royalty income tied to the company's beta-alanine intellectual property and trademarks.

The company sells primarily to private-label brands and distributors that market supplements and health products to end...

  • Private-label supplement brandsprimary

    Buy contract manufacturing for vitamins, minerals, herbs, and other nutritional supplements to sell under their own labels.

  • Health care product marketersprimary

    Outsource production and packaging of consumer health products where formulation quality and supply reliability matter.

  • Beta-alanine ingredient buyerssecondary

    Purchase CarnoSyn® or TriBsyn™ raw material for sports nutrition, wellness, healthy aging, and medical foods.

  • Licensees and royalty partnerssecondary

    Use the company's patents, trademarks, and trade names in exchange for licensing and royalty payments.

The company serves consumers both within and outside the U.S., but the filings provided do not disclose a country...

  • U.S. is the core market for contract manufacturing and ingredient sales
  • International sales are part of the customer base, but not separately disclosed
  • Swiss subsidiary in Manno supports manufacturing, warehousing, and distribution
  • Cross-border sourcing and shipping create tariff and supply chain exposure
  • Foreign exchange can affect reported results through the Swiss operation

Management is focused on diversifying away from a small customer base while improving utilization of its certified...

01
Customer diversificationshort-term

Reduces dependence on two or three large buyers and lowers order-timing volatility.

02
Beta-alanine commercializationmedium-term

Creates higher-margin IP-linked revenue streams beyond contract manufacturing.

03
Operational efficiencyshort-term

Better utilization and cost control can improve profitability in a low-margin manufacturing model.

The biggest company-specific risk is customer concentration, since a few private-label accounts can materially affect...

high

Customer concentration

Largest private-label customer represented 31% of total net sales in the six months ended Dec. 31, 2025.

Scope
A small number of customers drive a large share of revenue and order timing.
Materiality
high
medium

Tariffs and trade duties

The company says tariffs can affect its ability to adjust prices and forecast costs on time.

Scope
Imported ingredients and cross-border supply chains.
Materiality
medium
medium

Geopolitical instability

Conflict in Ukraine and the Middle East may disrupt supply chains and energy prices.

Scope
Global sourcing, logistics, and market volatility.
Materiality
medium
medium

Foreign exchange volatility

The Swiss subsidiary creates translation and transaction exposure.

Scope
Cross-border operations and non-U.S. activity.
Materiality
medium
Revenue recognition and volume rebates
Net revenue and gross margin
Quarterly seasonality and order timing
Comparability of quarterly results
Foreign currency translation
Reported earnings and equity

: 28/04/2026